课题基金 / 基金详情

ADRENERGIC DYSFUNCTION IN UREMIA

ADRENERGIC DYSFUNCTION IN UREMIA
尿毒症的肾上腺素能功能障碍
批准号:
3445968
负责人:
Leonard Gerald Meggs
金额:
$5.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-08-01 至 1986-07-31

项目摘要

项目成果

Leonard Gerald Meggs的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The partially nephrectomized uremic rat provides an excellent model to examine the effect of uremia on the adrenergic nervous system. Employing the uremic rat mesenteric vascular preparation, and the Gamma 1, selective radioligand (125I) IBE2254, the effect of uremia on the adrenergic effector component of systemic vascular resistance; the Gamma 1, vascular receptor, will be assessed. The hypothesis to be tested is chronic uremia results in a neurogenic form of hypertension, similar to that observed in experimental models with baroreceptor differentation. In such models, loss of tonic inhibition of sympathetic vasomotor outflow, results in sympathetically mediated vasoconstriction, increased catecholamine synthesis and hypertension. Specific objectives include: 1) To determine if the number of Gamma 1 vascular receptors is decreased in uremic rats. Physiologic states characterized by increased endogenous levels of catecholamines have been associated with down regulation of Gamma 1 vascular receptors. By determining plasma catecholamine levels, we will be able to correlate these with any changes in receptor number observed. 2) To determine if the affinity of the Gamma 1 vascular receptor is blunted or decreased by the uremic state. In a series of related investigations also performed in the uremic rat model, the effect of chronic uremia on density and affinity of myocardial B adrenergic receptors; and B receptor; adenyl cyclase coupling, will be examined.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Adaptive myocardial hypertrophy in the renal ablation model.
肾脏消融模型中的适应性心肌肥厚。
DOI: 10.1093/ajh/3.1.33
发表时间: 1990
期刊: American journal of hypertension
影响因子: 3.2
作者: [Meggs,LG, Ben-Ari,J, Gammon,D, Choudhury,M, Goodman,AI]
通讯作者: Goodman,AI
Effect of chronic uremia on the cardiovascular alpha 1 receptor.
慢性尿毒症对心血管α1受体的影响。
DOI: 10.1016/0024-3205(86)90452-2
发表时间: 1986
期刊: Life sciences
影响因子: 6.1
作者: [Meggs,LG, Ben-Ari,J, Gammon,D, Choudhury,M, Goodman,AI]
通讯作者: Goodman,AI
Amelioration of systemic hypertension by converting enzyme inhibition in the renal ablation model.
通过在肾脏消融模型中转化酶抑制来改善系统性高血压。
DOI: 10.1093/ajh/1.2.190
发表时间: 1988
期刊: American journal of hypertension
影响因子: 3.2
作者: [Meggs,LG, Garrick,R, Chander,P, Ben-Ari,J, Gammon,D, Goodman,AI]
通讯作者: Goodman,AI
Left ventricular response to exercise and autonomic control mechanisms in end-stage renal disease.
终末期肾病的左心室对运动和自主控制机制的反应。
DOI: --
发表时间: 1989
期刊: Archives of internal medicine
影响因子: --
作者: [Blake,JW, Solangi,KB, Herman,MV, Goodman,AA, Meggs,LG]
通讯作者: Meggs,LG
p66/Insulin Like Growth Factor-1 Reno-Protection in Diabetes
p66/Insulin Like Growth Factor-1 Reno-Protection in Diabetes
  • 批准号:
    8060785
  • 项目类别:
  • 资助金额:
    $9.83万
  • 财政年份:
    2008
  • 负责人:
    Leonard Gerald Meggs
  • 依托单位:
p66/Insulin Like Growth Factor-1 Reno-Protection in Diabetes
  • 批准号:
    8060724
  • 项目类别:
  • 资助金额:
    $8.61万
  • 财政年份:
    2008
  • 负责人:
    Leonard Gerald Meggs
  • 依托单位:
p66/Insulin Like Growth Factor-1 Reno-Protection in Diabetes
海外基金